ArticleJournal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology2026
E122Q rhodopsin: pigment microspectrophotometry, photoreceptor light responses, and bleaching adaptation.
Article in Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
When the rhodopsin visual pigment of vertebrate rods absorbs light, photoisomerization of its 11-cis retinal chromophore to all-trans retinal triggers a conformational change, ultimately leading to the formation of metarhodopsin II (meta II), the active signalling state. Meta II initiates the phototransduction cascade, culminating in membrane hyperpolarization. To investigate how meta II lifetime shapes the rod photoresponse, we studied a knock-in mouse expressing E122Q rhodopsin, a mutant pigment with a shortened meta II lifetime. Microspectrophotometry confirmed that E122Q rhodopsin is blue-shifted in its absorbance spectrum and exhibits significantly faster meta II decay than wild-type (WT). Patch-clamp recordings revealed that this shortened lifetime had little effect on response kinetics or on the dominant time constant of recovery after bright flashes. However, following pigment bleaching, rods expressing E122Q showed markedly greater desensitization than WT, indicating that free E122Q opsin activates the phototransduction cascade more efficiently in darkness. To our knowledge, this is the first report of a rhodopsin mutation that alters free opsin-driven activation of phototransduction. Given that many disease-causing mutations affect dark adaptation, such opsin-based mechanisms may be more common than previously appreciated.
Indexed as
Identifiers
42360335What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.